Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Condition:   Chemotherapy-induced Peripheral Neuropathy Interventions:   Drug: Calmangafodipir (2 µmol/kg);   Drug: Calmangafodipir (5 µmol/kg);   Drug: Placebo Sponsor:   PledPharma AB Not yet recruiting

Source: ClinicalTrials.gov - August 31, 2018 Category: Research Source Type: clinical trials